These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15667404)

  • 21. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
    Giannitsis E; Katus HA
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycoprotein IIb/IIIa antagonists in Takotsubo cardiomyopathy.
    Omar HR
    Herz; 2013 Nov; 38(7):740-2. PubMed ID: 23632423
    [No Abstract]   [Full Text] [Related]  

  • 23. Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome.
    Gill DS; Ng K; Ng KS
    Heart; 2004 Mar; 90(3):e15. PubMed ID: 14966076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction.
    Steen H; Lehrke S; Wiegand UK; Merten C; Schuster L; Richardt G; Kulke C; Gehl HB; Lima JA; Katus HA; Giannitsis E
    Am Heart J; 2005 Mar; 149(3):564. PubMed ID: 15864217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy.
    D'Urbano M; Barlocco F; Poli A; Fetiveau R; Vandoni P; Savonitto S; De Servi S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):737-41. PubMed ID: 18545078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
    Liebeskind DS; Pollard JR; Schwartz ED; Cucchiara BL; McGarvey ML; Hurst RW
    J Thromb Thrombolysis; 2002 Apr; 13(2):81-4. PubMed ID: 12101384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication.
    Yilmaz MB; Akin Y; Biyikoglu SF; Guray U; Korkmaz S
    Int J Cardiol; 2004 Jan; 93(1):81-2. PubMed ID: 14729442
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.
    Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S81-90. PubMed ID: 16124952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A misleading diagnosis in acute coronary syndrome: tirofiban-induced alveolar hemorrhage.
    Şarlı B; Uğurlu M; Tok A; Dondurmacı E; Sağ Ertürk F
    Turk Kardiyol Dern Ars; 2015 Dec; 43(8):753. PubMed ID: 26717345
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban.
    Hölschermann H; Krombach C; Jung A; Jacobi F; Tillmanns H; Weinand F
    Thromb Haemost; 2005 Sep; 94(3):684-6. PubMed ID: 16268493
    [No Abstract]   [Full Text] [Related]  

  • 33. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events.
    Dunkley S; Evans S; Gaudry L; Jepson N
    Platelets; 2005 Dec; 16(8):462-8. PubMed ID: 16287613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review.
    Elcioglu OC; Ozkok A; Akpınar TS; Tufan F; Sezer M; Umman S; Besısık SK
    Int J Hematol; 2012 Sep; 96(3):370-5. PubMed ID: 22767141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome.
    Kellert L; Hametner C; Rohde S; Bendszus M; Hacke W; Ringleb P; Stampfl S
    Stroke; 2013 May; 44(5):1453-5. PubMed ID: 23463755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 39. [Plaque inhibition with the GPIIb/IIIa antagonist Tirofiban].
    Z Kardiol; 1999 Apr; 88(4 Suppl):1-4. PubMed ID: 10355076
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of BP IIb/IIIa inhibitors].
    Polimeno S; De Rosa V
    Ital Heart J Suppl; 2000 Jul; 1(7):958-61. PubMed ID: 10935749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.